Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
The preemption doctrine could save Medtronic from the raft of lawsuits it’s facing over alleged off-label promotion of its InFuse bone putty.
Stryker Corp. says the recalls of a pair of hip implants could cost more than $1 billion, nearly double previous estimates, and the U.S. Securities & Exchange Commission charges the company with violating the Foreign Corrupt Practices Act in 5 countries, extracting a $13.2 million settlement.
Medical device giant Boston Scientific announces that it will cut between 1,100 to 1,500 employees worldwide under a new restructuring program aimed at streamlining its operations, as well as the departure of long-time CFO Jeff Capello amid strong 3rd-quarter results.